000 01810 a2200517 4500
005 20250513142445.0
264 0 _c19980608
008 199806s 0 0 eng d
022 _a0021-9738
024 7 _a10.1172/JCI1268
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAsai, O
245 0 0 _aSuppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cMay 1998
300 _a1835-42 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenocarcinoma
_ximmunology
650 0 4 _aAdoptive Transfer
650 0 4 _aAnimals
650 0 4 _aBone Marrow Transplantation
_ximmunology
650 0 4 _aColonic Neoplasms
_ximmunology
650 0 4 _aGraft vs Host Disease
_xmortality
650 0 4 _aImmunosuppressive Agents
_xpharmacology
650 0 4 _aInterleukin-2
_xpharmacology
650 0 4 _aIntestines
_ximmunology
650 0 4 _aKiller Cells, Natural
_xdrug effects
650 0 4 _aLiver
_ximmunology
650 0 4 _aLung Neoplasms
_xsecondary
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Inbred C3H
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, SCID
650 0 4 _aSkin
_ximmunology
650 0 4 _aTime Factors
650 0 4 _aTransforming Growth Factor beta
_ximmunology
650 0 4 _aTransplantation, Homologous
700 1 _aLongo, D L
700 1 _aTian, Z G
700 1 _aHornung, R L
700 1 _aTaub, D D
700 1 _aRuscetti, F W
700 1 _aMurphy, W J
773 0 _tThe Journal of clinical investigation
_gvol. 101
_gno. 9
_gp. 1835-42
856 4 0 _uhttps://doi.org/10.1172/JCI1268
_zAvailable from publisher's website
999 _c9543657
_d9543657